NASDAQ · Healthcare · Biotechnology
Regeneron Pharmaceuticals, Inc.
REGN
Regeneron Pharmaceuticals, Inc. CEO Leonard S. Schleifer · Market cap $74.2B.
$719.78
+7.01 · +0.98%
52w hi $821.1152w lo $476.49
44
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
1
1 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Oct 29 | Christine A Poon | Sell | 2,735 | $653.50 | −$1.79M | 32 | |
| Oct 29 | Christine A Poon | Sell | 1,915 | $654.42 | −$1.25M | 32 |
Section 02
Recent STOCK Act disclosures
1 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Mar 13 | Julia Letlow | House | Buy | $1,001 - $15,000 | $8K | 29 d | 44 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay